• Science & Technology

The scientists on a mission to revolutionise brain tumour research

Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research. Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.

17 June 2019

• Charity News

Cancer Research UK announces new chief medical officer for the Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development. Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development.

17 June 2019

• For Supporters

Glioblastoma and children’s brain tumours: teams awarded £18 million Cancer Research UK Brain Tumour Awards

Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop. Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.

17 June 2019

• Science & Technology
• Health & Medicine

News digest – NHS waiting times, prostate cancer scans, drug decisions and gut bacteria

In the news this week: NHS waiting times for cancer treatment ‘continue to spiral downwards’. In the news this week: NHS waiting times for cancer treatment ‘continue to spiral downwards’.

15 June 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Science & Technology
• Health & Medicine

News digest – obesity projections, immunotherapy trials, Vitamin D and cancer ‘cure’ documentaries

In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer. In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer.

8 June 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Health & Medicine
• Science & Technology

News digest – ultra-processed food, liquid gel spacer, night shift work and how breast cancer spreads 

In the news this week: no link found between night shift work and breast cancer. In the news this week: no link found between night shift work and breast cancer.

1 June 2019

• Health & Medicine

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe. An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

1 June 2019

• Health & Medicine

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial. Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

1 June 2019

• Science & Technology

ASCO 2019 news: targeted treatment takeover, drugging the ‘undruggable’, obesity and blood tests

The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers. The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.

31 May 2019